| HEMOSTEMIX INC. |
| Kanada |
| Gesundheit |
| CA4236943060 / A2QQGU |
| 2VF0 (Frankfurt) |
| FRA:2VF0, ETR:2VF0, 2VF0:GR |
| - |
| https://hemostemix.com/ |
|
Hemostemix Inc., a biotechnology company, specializes in developing treatments for blood-related disorders. The company's primary focus lies in harnessing the regenerative power of the body's own cells to treat various medical conditions. At the core..
>Volltext.. |
| 8.51 Mio. EUR |
| 9.82 Mio. EUR |
| - |
| -2.67 Mio. EUR |
| -2.11 Mio. EUR |
| -0.02 EUR |
| 2.14 Mio. EUR |
| 0.72 Mio. EUR |
| -3.22 Mio. EUR |
| 1.5 |
| - |
| -57.12% |
| - |
| - |
| - |
| - |
| HEMOSTEMIX |
| 05.04.26 |
|